Rosiglitazone stimulates peroxisome proliferator-activated receptor gamma expression and directly affects invitro steroidogenesis in porcine ovarian follicles

Theriogenology

Volumn 82, Issue 1, 2014, Pages 1-9

  Rak Mardyła, Agnieszka ^a   Karpeta, Anna ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Estrus cycle; Porcine ovarian follicles; PPAR ; Prepubertal; Rosiglitazone; Steroidogenesis

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; AROMATASE; HYDROXYSTEROID DEHYDROGENASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROGESTERONE; PROSTAGLANDIN E2; ROSIGLITAZONE; STEROID 17ALPHA MONOOXYGENASE; TESTOSTERONE;

AGONISTS; ANIMAL; DRUG EFFECTS; FEMALE; GENE EXPRESSION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; OVARY; OVARY FOLLICLE; PHYSIOLOGY; PIG;

17-HYDROXYSTEROID DEHYDROGENASES; 3-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; AROMATASE; DINOPROSTONE; FEMALE; GENE EXPRESSION; OVARIAN FOLLICLE; OVARY; PPAR GAMMA; PROGESTERONE; RNA, MESSENGER; STEROID 17-ALPHA-HYDROXYLASE; SWINE; TESTOSTERONE; THIAZOLIDINEDIONES;

EID: 84901439171     PISSN: 0093691X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.theriogenology.2014.02.016     Document Type: Article

References (32)

1. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 1995, 270:12953-12956.
2. Desvergne B., Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999, 20:649-688.
3. Camp H.S., Li O., Wise S.C., Hong Y.H., Frankowski C.L., Shen X., et al. Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone. Diabetes 2000, 49:539-547.
4. Hsueh W.A., Law R. The central role of fat and effect of peroxisome proliferator-activated receptor-gamma on progression of insulin resistance and cardiovascular disease. Am J Cardiol 2003, 18:3-9.
5. Komar C.M. Peroxisome proliferator-activated receptors (PPARs) and ovarian function-implications for regulating steroidogenesis, differentiation, and tissue remodeling. Reprod Biol Endocrinol 2005, 3:41.
6. Froment P., Gizard F., Defever D., Staels B., Dupont J., Monget P. Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition. J Endocrinol 2006, 189:199-209.
7. Stout D.L., Fugate S.E. Thiazolidinediones for treatment of polycystic ovary syndrome. Pharmacotherapy 2005, 25:244-252.
8. Mohiyiddeen L., Watson A.J., Apostolopoulos N.V., Berry R., Alexandraki K.I., Jude E.B. Effects of low-dose metformin and rosiglitazone on biochemical, clinical, metabolic and biophysical outcomes in polycystic ovary syndrome. J Obstet Gynaecol 2013, 33:165-170.
9. Pasquali R., Gambineri A. Insulin-sensitizing agents in polycystic ovary syndrome. Eur J Endocrinol 2006, 154:763-775.
10. Kim J., Sato M., Li Q., Lydon J.P., Demayo F.J., Bagchi I.C., et al. Peroxisome proliferator-activated receptor gamma is a target of progesterone regulation in the preovulatory follicles and controls ovulation in mice. Mol Cell Biol 2008, 28:1770-1782.
11. Minge C.E., Bennett B.D., Norman R.J., Robker R.L. Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reverses the adverse effects of diet-induced obesity on oocyte quality. Endocrinology 2008, 149:2646-2656.
12. Chen Q., Sun X., Chen J., Cheng L., Wang J., Wang Y., et al. Direct rosiglitazone action on steroidogenesis and proinflammatory factor production in human granulosa-lutein cells. Reprod Biol Endocrinol 2009, 7:147.
13. Froment P., Fabre S., Dupont J., Pisselet C., Chesneau D., Staels B., et al. Expression and functional role of peroxisome proliferator-activated receptor-gamma in ovarian folliculogenesis in the sheep. Biol Reprod 2003, 69:1665-1674.
14. Swindle M.M., Smith A.C. Comparative anatomy and physiology of the pig. Scand J Lab Anim Sci 1998, 25:1-10.
15. Gregoraszczuk E., Bylica A., Gertler A. Response of porcine theca and granulosa cells to GH during short-term invitro culture. Anim Reprod Sci 2000, 58:113-125.
16. Seto-Young D., Avtanski D., Strizhevsky M., Parikh G., Patel P., Kaplun J., et al. Interactions among peroxisome proliferator activated receptor-gamma, insulin signaling pathways, and steroidogenic acute regulatory protein in human ovarian cells. J Clin Endocrinol Metab 2007, 92:2232-2239.
17. Ptak A., Ludewig G., Lehmler H.J., Wójtowicz A.K., Robertson L.W., Gregoraszczuk E.L. Comparison of the actions of 4-chlorobiphenyl and its hydroxylated metabolites on estradiol secretion by ovarianfollicles in primary cells in culture. Reprod Toxicol 2005, 20:57-64.
18. Gregoraszczuk E., Rak-Mardyła A. Supraphysiological leptin levels shifts the profile of steroidogenesis in porcine ovarian follicles toward progesterone and testosterone secretion through increased expression of CYP11A1 and 17b-HSD: a tissue culture approach. Reproduction 2013, 145:311-317.
19. Rak-Mardyła A., Durak M., Gregoraszczuk E.L. Effects of resistin on porcine ovarian follicle steroidogenesis in prepubertal animals: an invitro study. Reprod Biol Endocrinol 2013, 11:45.
20. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
21. Rak-Mardyla A., Gregoraszczuk E.L. Expression of ghrelin and its receptor in porcine ovarian follicles collected from prepubertal and estrous cycle animals. J Physiol Pharmacol 2012, 63:195-199.
22. Sharma I., Monga R., Singh N., Datta T.K., Singh D. Ovary-specific novel peroxisome proliferator activated receptors-gamma transcripts in buffalo. Gene 2012, 504:245-252.
23. Seto-Young D., Paliou M., Schlosser J., Avtanski D., Park A., Patel P., et al. Direct thiazolidinedione action in the human ovary: insulin-independent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production. J Clin Endocrinol Metab 2005, 90:6099-6105.
24. Schoppee P.D., Garmey J.C., Veldhuis J.D. Putative activation of theperoxisome proliferator-activated receptor gamma impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells. Biol Reprod 2002, 66:190-198.
25. Löhrke B., Viergutz T., Shahi S.K., Pöhland R., Wollenhaupt K., Goldammer T., et al. Detection and functional characterisation of the transcription factor peroxisome proliferator-activated receptor gamma in lutein cells. J Endocrinol 1998, 159:429-439.
26. Komar C.M., Braissant O., Wahli W., Curry T.E. Expression and localization of PPARs in the rat ovary during follicular development and the periovulatory period. Endocrinology 2001, 142:4831-4838.
27. Gasic S., Bodenburg Y., Nagamani M., Green A., Urban R.J. Troglitazone inhibits progesterone production in porcine granulosa cells. Endocrinology 1998, 139:4962-4966.
28. Forman B.M., Tontonoz P., Chen J., Brun R.P., Spiegelman B.M., Evans R.M. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 1995, 83:803-812.
29. Dereli D., Dereli T., Bayraktar F., Ozgen A.G., Yilmaz Endocrine and metabolic effects of rosiglitazone in non-obese women with polycystic ovary disease. Endocr J 2005, 52:299-308.
30. Veldhuis J.D., Zhang G., Garmey J.C. Troglitazone, an insulin-sensitizing thiazolidinedione, represses combined stimulation by LH and insulin of de novo androgen biosynthesis by thecal cells invitro. J Clin Endocrinol Metab 2002, 87:1129-1133.
31. Arlt W., Auchus R.J., Miller W.L. Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3beta-hydroxysteroid dehydrogenase. J Biol Chem 2001, 276:16767-16771.
32. Seto-Young D., Avtanski D., Parikh G., Suwandhi P., Strizhevsky M., Araki T., et al. Rosiglitazone and pioglitazone inhibit estrogen synthesis in human granulosa cells by interfering with androgen binding to aromatase. Horm Metab Res 2011, 43:250-256.